Technology | Ultrasound Imaging | September 06, 2017

New feature on Acuson SC2000 integrates advanced ultrasound and angiographic imaging for improved navigation and guidance during structural heart disease interventions

Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature

September 6, 2017 — The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens Healthineers that integrates ultrasound and angiography to guide cardiac teams when administering treatment for structural heart disease. Available on the new Release 5.0 of the Acuson SC2000 cardiovascular ultrasound system, TrueFusion is designed to maximize not only interventional cardiology procedures, but also routine diagnosis and follow-up of patients with structural heart disease.

Treatment options for structural heart disease are evolving rapidly. Increasingly, these minimally invasive procedures involve multimodality cardiac imaging and multidisciplinary clinical teams. To reliably diagnose structural heart disease and perform these complex interventions, clinical teams need detailed, real-time imaging information — specifically, real-time soft tissue and blood flow information from echocardiography as well as 2-D imaging information from fluoroscopy — to be visible in one view for common orientation.

Addressing the need for fused images, the new TrueFusion application sends anatomical and functional markers as well as valve models from the Acuson SC2000’s True Volume transesophageal echocardiography (TEE) transducer to an Artis with Pure angiography system, overlaying ultrasound information with live fluoroscopy images to navigate structural heart procedures. By directly and seamlessly integrating co-registration of Artis fluoro and Acuson SC2000 echo into the workflow via machine learning-based probe detection and automated registration updates, TrueFusion enables clinical teams to identify soft tissue-based structures that are provided directly from the integrated ultrasound system. With TrueFusion, not only can echocardiographers and interventionists better communicate and achieve more intuitive anatomical orientation during challenging procedures, but clinical teams potentially can reduce contrast usage and procedure time as well as patient and clinician X-ray exposure.

TrueFusion represents a workflow consisting of syngo TrueFusion (syngo X Workplace) and TrueFusion echo-fluoro guidance (Acuson SC2000 Ultrasound System, Prime edition).

For more information: www.usa.healthcare.siemens.com

Related Content

News | Radiology Business

August 12, 2022 — Clarius Mobile Health, a leading provider of high-definition wireless ultrasound systems, announced ...

Time August 12, 2022
arrow
News | Ultrasound Imaging

August 10, 2022 — Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ...

Time August 10, 2022
arrow
News | Point-of-Care Ultrasound (POCUS)

August 10, 2022 — Mindray North America, a global leader and developer of healthcare technologies and solutions for ...

Time August 10, 2022
arrow
News | Contrast Media

August 2, 2022 – A new update has been announced as the radiology world continues to address supply disruptions of ...

Time August 02, 2022
arrow
News | Mobile C-Arms

July 29, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ...

Time July 29, 2022
arrow
News | Artificial Intelligence

July 26, 2022 — Aidoc, a leading provider of AI healthcare solutions, today announced a partnership with UofL Health, a ...

Time July 26, 2022
arrow
News | Computed Tomography (CT)

July 21, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), an AI tool for detection of incidental ...

Time July 22, 2022
arrow
News | AHRA

July 18, 2022 — 3DR Labs, an Accumen company, today announced the launch of its Cardiac Center of Excellence and Imaging ...

Time July 19, 2022
arrow
News | Focused Ultrasound Therapy

July 5, 2022 — Focused Ultrasound, an innovative, new procedure being used by USF Health Morsani College of Medicine ...

Time July 05, 2022
arrow
News | Radiology Business

July 1, 2022 — Richard Fabian has been promoted to the role of Chief Executive Officer (CEO) of Fujifilm Sonosite, Inc ...

Time July 01, 2022
arrow
Subscribe Now